发明名称 |
BENZOIMIDAZOLE DERIVATIVES AS SIRTUIN (SIR) MODULATING COMPOUNDS |
摘要 |
A. Provided herein are novel sirtuin-modulating compounds of formula (I) and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent ( I ), wherein: one of R1 R2 R3 or R4 is selected from a 5- to 6-membered heteroaryl comprising 1 to 3 heteroatoms 'independently selected from N, O or S, wherein said heteroaryl is optionally benzofused or optionally fused to a second 5- to 6-membered heteroaryl comprising 1 to 3 heteroatoms independently selected from N, O or S and is bound to the rest of the compound via a carbon ring atom, wherein said heteroaryl is optionally substituted on a single carbon ring atom with a substituent selected from a solubilizing group, or a C1-C4 straight or branched alkyl.
|
申请公布号 |
WO2008073451(A8) |
申请公布日期 |
2008.12.11 |
申请号 |
WO2007US25391 |
申请日期 |
2007.12.11 |
申请人 |
SIRTRIS PHARMACEUTICALS, INC.;BEMIS, JEAN;VU, CHI, B.;NUNES, JOSEPH, J.;ARMISTEAD, DAVID |
发明人 |
BEMIS, JEAN;VU, CHI, B.;NUNES, JOSEPH, J.;ARMISTEAD, DAVID |
分类号 |
C07D417/14;A61K31/429;C07D417/04 |
主分类号 |
C07D417/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|